Answers are grounded in this paper and cite their sources.
Botulinum toxin may represent a promising agent in the management of keloid scars. However, further research involving large-scale studies with comparative designs and long-term follow-up is warranted to delineate the value of this therapeutic modality in scar management protocols.
No takes yet. Share an insight, caveat, or question.
Sohrabi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: